Healthcare and Life Science
Exonate appoints Dr Rafiq Hasan as Non-Executive Director
Appointment brings extensive experience in global pharma leadership and progressing ophthalmology drugs to market and further strengthens Board ...
Introducing new video series: "Power Query for Newbies"
Computer Tutoring are excited to launch "Power Query for Newbies," a comprehensive video series aimed at beginners and new users eager to master Power Query in Excel. This series will guide you through essential data cleaning and preparation techniques. Learn how to remove blank rows, u...
Sphere Fluidics appoints Curtis Nicholson as Director of Sales, EMEA, to support accelerated growth in key markets
Cambridge, UK, 23 May, 2024: Sphere Fluidics, a leading provider of innovative microfluidics-based solutions for single-cell analysis and isolation, today announced the appointment of Curtis Nicholson as Director of Sales for Europe, Middle East, and Africa (EMEA). Curtis’ appointment w...
Closed Loop Medicine appoints Paul Johnson as Non-Executive Director
Appointment of digital healthcare leader to Board to support the Company as it enters next phase of commercial development Co-founder and former CEO of Lemonaid Health, a leading innovator in telemedicine and prescription drug delivery, acquired by 23andMe in 2021 London, UK, 22 M...
The science sector could be missing out on unlocking Neurodiverse potential by not knowing about this UK Government scheme
Companies in the science sector in the Cambridge area could be missing out on unlocking latent strengths of neurodiverse employees because they either don't know about or avoid using the UK Government's Access To Work Scheme. ...
UK proteostasis community comes together for a successful inaugural event
The UK’s proteostasis community came together for the first event of the UK Proteostasis Network at the Institute. ...
PhoreMost introduces GlueSEEKER platform for discovery of molecular glue degraders
New drug discovery platform integrates computational approaches with molecular biology for development of novel degrader therapeutics Cambridge, UK, 21 May 2024: PhoreMost Ltd., a leading UK biopharmaceutical company unlocking the next generation of drug targets, announces the introdu...
Deloitte Cambridge opens new business lounge
The Life Sciences Catalyst Business Lounge, designed to be a regional hotspot for start-ups and world-leading businesses in the life sciences sector, has been opened by Deloitte Cambridge. ...
Assessment of the impact of earlier access to disease-modifying treatments with more convenient administration frequency in reducing the socioeconomic burden for multiple sclerosis patients in Europe
The socioeconomic impact of Multiple Sclerosis (MS) extends to various areas of a patient’s life including personal wellbeing and mental health, family life and planning, employment and the lives of caregivers, which is associated with a significant economic and societal burden. Advance...
AT278 ultra-concentrated ultra-rapid acting insulin demonstrates superiority in Phase I Clinical Trial in overweight and obese people with type 2 diabetes
AT278 demonstrates significantly accelerated PK/PD profile compared to NovoRapid® and Humulin® R U-500 in people with Type 2 Diabetes and high BMI ...